Good Morning,
I wanted to share the market commentary from a
dividend growth investor friend of mine, who manages money. This is not a paid post, and I do not receive any compensation from him. Rather, I have interacted with Joe off and on over the past decade. He is one of those readers who have stuck around for a while, who I regularly discuss dividend investing with. Writing about investing can be a lonely pursuit, so it is definitely helpful to have someone and bounce off ideas.
I am sharing this market commentary, which he shared privately with his clients, because a lot of his points resonate very well with me. While no two investors are alike, his strategy of finding quality dividend payers for the long term really hits home for me. The letter captures current market sentiment, investing strategy, lessons learned and general commentary. If I ever leave blogging to manage money full time, this is the type of letter I would be sharing with clients.
There are a number of reasons for this.
Before the presidential election in November 2016, I thought that the Blue Team would win, and that minimum wage would be gradually raised, inflation would creep up, and goods and services would earn more revenues. This would put a higher floor in our companies' earnings, spurring the market to pay a higher multiple for our companies' earnings.
Well, as we all know, the Red Team won, and now, minimum wage is being gradually raised [2], inflation is creeping up, and our company's goods and services are earning more revenues. It's funny how that happens.
There is also the matter of the large corporate tax cut, which gives our companies more after-tax profits. The market has been excited by that.
We have seen a number of US companies either attempt (in the case of Pfizer and Allergan) or execute (Medtronic, Johnson Controls, etc) foreign inversions in the past decade, so it makes sense to me that incentives should be provided for US companies to not pack up and run to lower tax regions. However, they should also have more regulations on tax avoidance, and that is indeed happening, with some companies getting rid of their tax shelters [3].
|
|
In 2016, many Summer Fields Investments accounts beat the broader market due to us buying selected financials when they were depressed during the summer Brexit vote. 2017 presented a higher hurdle. The last time we bought Boeing was when they were under investigation by the SEC for accounting irregularities, in the first quarter of 2016, for approximately 114 per share. This presented an opportunity that we always search for- a good company which is going through temporary drama that depressed share value. Since early 2016, Boeing share price has gone up to around 333, a 192% return in the past 2 years. Much of that rise happened since the election. In January 2017, it started at 157, where I thought it was already richly valued, and went up another $199 in 2017, a 126% return in 2017. Boeing is now very overvalued, in my opinion, trading well over historical market multiples. Being that the Dow Jones Index is only 30 companies, Boeing dragged the Dow up very high in 2017, to around 26%. The S&P returned 19.4% for the year.
This type of behavior is a characteristic of a more mature phase in the market cycle and in the bull market. There is a lot of global liquidity and people want to put their money to work as they see the market gaining over the past years. Excited investors pile into the winners, and those that already have appreciated a lot attract even more capital. We see this especially in the FAANG stocks- Facebook, Apple, Amazon, Netflix, and Google. It has been tough to compete with that kind of excitement in 2017 on a total return basis. However, all of your accounts have done well in 2017, most comfortably in high double digit territory, and some of you exceeding 20% for the year. All of you, of course, have higher current dividend yields than the richly valued S&P, now yielding around 1.84%. The Dow also similarly yields around 1.99%, also fairly expensive.
In January 2018, many of our companies have joined the market excitement. Abbvie, which many of us own, went up 15%, more than doubling in the past year (unjustifiably, in my opinion- the market is overexcited about short term catalysts in the stock, including Abbvie winning a lawsuit which extends patent protection of Humira for a little longer than anticipated). Target Corp. went up almost 40% in the past few months, and 12% since the beginning of the year. Long term market returns can often be lumpy.
Of course, leading into February, the market has been in correction mode. I will address my thoughts on the current state of the markets and my projections for the future later on in this update. |
|
|
|
Have a great weekend!